Search research articles
Contact Us
Filters
Showing results (161-170 of 179) with videos related to
Page
of 18
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 3, 2015
70-kDa heat shock protein coated magnetic nanocarriers as a nanovaccine for induction of anti-tumor immune response in experimental glioma
Maxim A Shevtsov, Boris P Nikolaev, Liudmila Y Yakovleva, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 22, 2016
The discovery of quinoline based single-ligand human H<sub>1</sub> and H<sub>3</sub> receptor antagonists
Panayiotis A Procopiou, Rachael A Ancliff, Paul M Gore, et al.
Oncogene
|
March 3, 2015
Wnt7a is a novel inducer of β-catenin-independent tumor-suppressive cellular senescence in lung cancer
R K Bikkavilli, S Avasarala, M Van Scoyk, et al.
Journal of Anatomy
|
January 27, 2009
Comparative microanatomy of the orbicularis oris muscle between chimpanzees and humans: evolutionary divergence of lip function
Carolyn R Rogers, Mark P Mooney, Timothy D Smith, et al.
British Journal of Pharmacology
|
July 24, 2010
A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model
J S Swaney, C Chapman, L D Correa, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 14, 2005
(1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: a novel class of potent MSK-1-inhibitors
Mark J Bamford, Michael J Alberti, Nicholas Bailey, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
February 26, 2017
A survey on IVIVC/IVIVR development in the pharmaceutical industry - Past experience and current perspectives
M A Nguyen, T Flanagan, M Brewster, et al.
Scientific Reports
|
January 14, 2025
Targeted dual biologic therapy for erythroderma of unknown etiology guided by high-parameter peripheral blood immunophenotyping
Hannah L Cornman, Martin P Alphonse, Arbor Dykema, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 16, 2008
The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase
Andrew K Takle, Mark J Bamford, Susannah Davies, et al.
The Journal of Infectious Diseases
|
December 28, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare Setting
Ellen C Hughes, Julien A R Amat, Joanne Haney, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 179) with videos related to
Sort By:
Page
of 18
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 3, 2015
70-kDa heat shock protein coated magnetic nanocarriers as a nanovaccine for induction of anti-tumor immune response in experimental glioma
Maxim A Shevtsov, Boris P Nikolaev, Liudmila Y Yakovleva, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 22, 2016
The discovery of quinoline based single-ligand human H<sub>1</sub> and H<sub>3</sub> receptor antagonists
Panayiotis A Procopiou, Rachael A Ancliff, Paul M Gore, et al.
Oncogene
|
March 3, 2015
Wnt7a is a novel inducer of β-catenin-independent tumor-suppressive cellular senescence in lung cancer
R K Bikkavilli, S Avasarala, M Van Scoyk, et al.
Journal of Anatomy
|
January 27, 2009
Comparative microanatomy of the orbicularis oris muscle between chimpanzees and humans: evolutionary divergence of lip function
Carolyn R Rogers, Mark P Mooney, Timothy D Smith, et al.
British Journal of Pharmacology
|
July 24, 2010
A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model
J S Swaney, C Chapman, L D Correa, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 14, 2005
(1H-imidazo[4,5-c]pyridin-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: a novel class of potent MSK-1-inhibitors
Mark J Bamford, Michael J Alberti, Nicholas Bailey, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
February 26, 2017
A survey on IVIVC/IVIVR development in the pharmaceutical industry - Past experience and current perspectives
M A Nguyen, T Flanagan, M Brewster, et al.
Scientific Reports
|
January 14, 2025
Targeted dual biologic therapy for erythroderma of unknown etiology guided by high-parameter peripheral blood immunophenotyping
Hannah L Cornman, Martin P Alphonse, Arbor Dykema, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 16, 2008
The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase
Andrew K Takle, Mark J Bamford, Susannah Davies, et al.
The Journal of Infectious Diseases
|
December 28, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare Setting
Ellen C Hughes, Julien A R Amat, Joanne Haney, et al.
Page
of 18